Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient.
about
Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceTwo years after pandemic influenza A/2009/H1N1: what have we learned?Drug resistance in influenza A virus: the epidemiology and management.Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus.Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo ExperimentsDeep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance.Drug-resistant pandemic (H1N1) 2009, South Korea.In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275YA zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir.Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit.Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USA.
P2860
Q28282405-DAA61F3D-40DB-4197-BFA5-C81F7BD6D244Q30224656-EF5659B4-B1C7-463D-86CA-40F43B0B83A0Q30234600-10560255-B0DF-4625-BDD5-A4F6C3636C6DQ30352689-A509D8BA-65EE-4352-BF05-54CE1D4A0393Q30393969-42E386FD-0BE9-4F6E-870E-802155853CA6Q30399274-139EB023-28A9-4F81-9B89-8679A4A9F816Q30401593-8B35F8AA-8E98-4CD7-B097-8D7E743619D3Q30416440-5BA804BC-1F9B-43BD-BC0B-9F02A9774226Q30420810-17D73056-2AB4-408B-B571-4978FEE2908CQ33910008-01426949-7675-4065-BE67-448A56F12C98Q39508037-19ECF648-751C-44BE-B8DE-42285C827EACQ40318096-CA21B3C0-58AF-4AB4-8977-BB846F73CB8DQ46139825-377A1952-FA74-4487-9D55-8C7EE462A20E
P2860
Oseltamivir-resistant 2009-2010 pandemic influenza A (H1N1) in an immunocompromised patient.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Oseltamivir-resistant 2009-201 ...... an immunocompromised patient.
@ast
Oseltamivir-resistant 2009-201 ...... an immunocompromised patient.
@en
type
label
Oseltamivir-resistant 2009-201 ...... an immunocompromised patient.
@ast
Oseltamivir-resistant 2009-201 ...... an immunocompromised patient.
@en
prefLabel
Oseltamivir-resistant 2009-201 ...... an immunocompromised patient.
@ast
Oseltamivir-resistant 2009-201 ...... an immunocompromised patient.
@en
P2093
P1476
Oseltamivir-resistant 2009-201 ...... n an immunocompromised patient
@en
P2093
A M Gabonay
J M Larkin
S P LaRosa
P304
P356
10.1111/J.1469-0691.2010.03212.X
P577
2010-10-01T00:00:00Z